Blood Testing

Our guest is Dr. Vinayak K. Prasad, a practicing hematologist-oncologist and internal medicine physician based in San Francisco. He joins us to discuss his important new book, "Malignant: How Bad Policy and Bad Evidence Harm People with Cancer." This work explains how hype, money, and bias can -- and often do -- mislead the public into thinking that many worthless or unproven cancer treatments are effective. As noted by Dr. David P.

Our guest on ST Medical Monday is Mikkael Sekeres, a leading cancer specialist who writes regularly for The New York Times. He tells us about his new book, "When Blood Breaks Down: Life Lessons from Leukemia." This work carefully examines leukemia in its different forms as well as the development of drugs to treat it.

On this edition of StudioTulsa, we meet investigative journalist John Carreyrou, a two-time Pulitzer winning reporter with the Wall Street Journal, who broke the story of the fraud perpetrated by the medical tech company Theranos and its young CEO Elizabeth Holmes. The company had purportedly created a device that would revolutionize blood testing, utilizing just a few drops of blood, but was found to be a sham. At its peak, Theranos had a market value of $10 billion and its flawed prototype was actually in market testing in California and Arizona before Carreyrou helped expose the fraud.